Quantcast

Latest Hydrazines Stories

2014-10-23 08:34:33

REHOVOT, Israel, October 23, 2014 /PRNewswire/ -- NeuroDerm Ltd., a clinical stage pharmaceutical company developing drugs for central nervous system (CNS) diseases, today announced that top-line results for ND0612L from a phase II study in patients with moderate Parkinson's patients, and preliminary interim results from a phase IIA study of ND0612H and ND0612L in advanced Parkinson's patients, will be presented at The Michael J. Fox Foundation's 2014 Parkinson's Disease...

2014-08-04 08:27:58

REHOVOT, Israel, August 4, 2014 /PRNewswire/ -- NeuroDerm [http://www.neuroderm.com ] Ltd. today announced that the European Medicines Agency (EMA) has deemed ND0612H, its product candidate offering continuous delivery of levodopa/carbidopa (LD/CD) treatment for advanced Parkinson's disease, eligible for a European Union marketing authorization application procedure ("centralized procedure"). According to EMA guidelines, the EMA can allow products for which the centralized...

2013-09-17 23:02:46

MarketPublishers.com announces that a new research study on the monomethylhydrazine (CAS 60-34-4) market created by BAC Reports is available in its catalogue. London, UK (PRWEB) September 17, 2013 MarketPublishers.com announces that a new research study on the monomethylhydrazine (CAS 60-34-4) market created by BAC Reports is available in its catalogue. The newly published report “Monomethylhydrazine (CAS 60-34-4) Market Research Report 2013” offers in-depth insights into the...

2012-06-21 23:02:01

A new delivery method for levodopa/carbidopa, a common dual-drug Parkinson´s disease (PD) regimen, significantly improved the duration of the drugs´ effectiveness in people with advanced PD, according to research led by Dr. C. Warren Olanow at Mount Sinai School of Medicine. New York, NY (PRWEB) June 21, 2012 A new delivery method for levodopa/carbidopa, a common dual-drug Parkinson´s disease (PD) regimen, significantly improved the duration of the drugs´ effectiveness...

2012-04-18 10:48:00

A levodopa-carbidopa intestinal gel (LCIG) works better than standard oral levodopa-carbidopa in reducing "off" time in patients with advanced Parkinson's disease. That's according to results of the phase three randomized, double-blind clinical trial of LCIG, to be presented as part of the Emerging Science program (formerly known as Late-Breaking Science) at the American Academy of Neurology's 64th Annual Meeting in New Orleans April 21 to April 28, 2012. "Off" time occurs when Parkinson's...


Word of the Day
conjunto
  • A style of popular dance music originating along the border between Texas and Mexico, characterized by the use of accordion, drums, and 12-string bass guitar and traditionally based on polka, waltz, and bolero rhythms.
The word 'conjunto' comes through Spanish, from Latin coniūnctus, past participle of coniungere, to join together; see conjoin